Breslow density ability to predict melanoma survival: should it be used in clinical practice?
Breslow density (BD) is an estimation of melanoma volume, which has emerged as a novel histopathological prognostic biomarker. To evaluate the role of BD as a predictor of patients' survival and assess its prognostic value in relation to overall survival (OS), disease-free survival (DFS), melan...
Saved in:
Published in | Clinical and experimental dermatology Vol. 50; no. 1; pp. 56 - 61 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
23.12.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!